Cadrenal Therapeutics
Ponte Vedra Beach
About Cadrenal Therapeutics
Cadrenal Therapeutics is a biopharmaceutical company developing a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation. The company was founded in 2022 and is headquartered in Ponte Vedra Beach, Florida.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $17.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2024)
- Ticker: nasdaq:CVKD
- Website: cadrenal.com
- Phone: 904.300.0701
Industries & Categories
Biopharma, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cadrenal-therapeutics-98477 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.